Integrated Management of Sales, Development and Manufacturing
First written in FY2021. 2 of 3 entries say "Advanced", first in FY2023. Latest entry: FY2026.
The whole theme swung hardest in 2024: 4 of 23 companies on the "Worse" side.
28 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「We are promoting ambidextrous R&D that advances the deepening of existing businesses and the exploration of new fields in parallel. Building on a technological foundation of imparting advanced functionality through the purification, synthesis, modification and compounding of raw materials, as well as technologies for evaluating product properties that meet customer requirements, we are conducting R&D in specialty lubricants, synthetic lubricants, hot-melt adhesives and new business divisions suited to a carbon-neutral society.」
Ambidextrous R&D advancing existing businesses and new fields simultaneously was presented in connection with specific technological foundations and target businesses. - FY2023AdvancedAnnual report
「In research and development, we have built a structure focused on developing products that respond quickly to customer needs in each market. Going forward, we will advance ambidextrous R&D capable of addressing social issues by synchronizing existing and new technologies, while expanding collaboration across business divisions and strengthening cooperation with overseas subsidiaries and universities.」
The R&D structure was made more concrete by expanding collaboration among sales, development, manufacturing and other functions to include cross-business coordination, overseas subsidiaries and universities, and by combining existing and new technologies. - FY2021First statedAnnual report
「Through an integrated management approach that combines the respective strengths of sales, development and manufacturing, we will further accelerate initiatives in existing business areas such as environmental, information and energy-device fields, as well as in new business areas expected to generate future growth, including life sciences.」
For the first time, the company has explicitly identified an approach that integrates the strengths of sales, development and manufacturing to accelerate initiatives in existing and new business areas.